Laurus Global Equity Management Inc. Buys 11,990 Shares of Integer Holdings Corporation $ITGR

Laurus Global Equity Management Inc. raised its position in shares of Integer Holdings Corporation (NYSE:ITGR) by 21.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 66,900 shares of the medical equipment provider’s stock after acquiring an additional 11,990 shares during the period. Integer makes up 4.7% of Laurus Global Equity Management Inc.’s portfolio, making the stock its 7th biggest position. Laurus Global Equity Management Inc. owned about 0.19% of Integer worth $6,913,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Emerald Advisers LLC raised its holdings in shares of Integer by 1,542.0% during the 2nd quarter. Emerald Advisers LLC now owns 103,824 shares of the medical equipment provider’s stock valued at $12,767,000 after buying an additional 97,501 shares during the period. Massachusetts Financial Services Co. MA acquired a new position in shares of Integer during the third quarter worth $41,938,000. Wakefield Asset Management LLLP purchased a new position in shares of Integer in the second quarter valued at $1,118,000. Cooke & Bieler LP grew its holdings in Integer by 35.7% during the 3rd quarter. Cooke & Bieler LP now owns 384,489 shares of the medical equipment provider’s stock valued at $39,729,000 after purchasing an additional 101,086 shares in the last quarter. Finally, SG Americas Securities LLC increased its stake in Integer by 127.3% during the 3rd quarter. SG Americas Securities LLC now owns 45,951 shares of the medical equipment provider’s stock worth $4,748,000 after buying an additional 25,732 shares during the period. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Key Integer News

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Integer will exhibit integrated R&D solutions and expanded coating capabilities at MD&M West (Feb. 3–5), which may support business development and customer visibility in its CDMO/device segments. Integer to Highlight Integrated R&D Solutions and Expanded Coating Capabilities During MD&M West 2026
• Neutral Sentiment: Multiple law firms are issuing procedural notices reminding investors of the Feb. 9 lead‑plaintiff deadline; these solicitations increase publicity but are routine in class actions and do not by themselves change the company’s legal exposure. Rosen Law Firm lead plaintiff deadline notice
• Negative Sentiment: Class action filings allege securities fraud tied to a lowered sales outlook and claims Integer overstated demand for its EP devices; plaintiffs point to a prior ~32% stock decline. This raises potential liability, settlement risk, and ongoing reputational pressure on the stock. BFA Law securities fraud filing notice
• Negative Sentiment: A broad set of plaintiff firms (Rosen, Glancy Prongay & Murray, Levi & Korsinsky, Pomerantz, Kahn Swick & Foti, Kuehn Law, Berger Montague, Bernstein Liebhard, et al.) are soliciting lead‑plaintiff candidates and investigating alleged fiduciary breaches and misstatements about EP market positioning—increasing legal activity and media attention that can weigh on investor sentiment and valuation multiples. Kuehn Law investor notice

Analyst Ratings Changes

A number of analysts have recently issued reports on ITGR shares. Wall Street Zen lowered Integer from a “buy” rating to a “hold” rating in a research report on Sunday. Raymond James Financial reissued an “outperform” rating and set a $95.00 price target (down previously from $143.00) on shares of Integer in a research report on Friday, October 24th. Citigroup upped their price target on shares of Integer from $69.00 to $75.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Truist Financial raised their price objective on shares of Integer from $86.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Finally, Benchmark restated a “hold” rating on shares of Integer in a research note on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Integer has a consensus rating of “Hold” and an average target price of $98.38.

Insider Activity at Integer

In other news, Director Cheryl C. Capps bought 1,600 shares of the firm’s stock in a transaction on Thursday, November 6th. The stock was purchased at an average price of $66.70 per share, for a total transaction of $106,720.00. Following the transaction, the director owned 11,702 shares in the company, valued at approximately $780,523.40. This trade represents a 15.84% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Tommy P. Thomas sold 884 shares of Integer stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $70.15, for a total value of $62,012.60. Following the sale, the vice president directly owned 3,596 shares in the company, valued at approximately $252,259.40. This trade represents a 19.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 2.16% of the stock is currently owned by insiders.

Integer Price Performance

Shares of NYSE ITGR opened at $85.93 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 3.71 and a quick ratio of 2.45. The firm has a market capitalization of $3.01 billion, a PE ratio of 35.95, a P/E/G ratio of 0.79 and a beta of 0.78. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $146.36. The business’s fifty day moving average price is $77.75 and its two-hundred day moving average price is $91.16.

Integer announced that its Board of Directors has authorized a share repurchase program on Tuesday, November 4th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the medical equipment provider to repurchase up to 8.3% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its stock is undervalued.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.